Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma Treatment with OligoPhoreTM siRNA stops aggressive ATLL tumor growth to near zeroSignificant reduction in tumor size, spleen size and peripheral blood lymphocyte countsResults add to extensive body of...

Auris Medical Provides Update on Bentrio Program in Allergy BentrioTM meets primary efficacy endpoint in clinical evaluation in allergic rhinitisClinically relevant and significant reduction in nasal symptomsSuperior efficacy ratings by patients and clinicians...

Employers Offering Vision Insurance Save $5.8 Billion on Healthcare RANCHO CORDOVA, Calif., Feb. 3, 2014 (GLOBE NEWSWIRE) -- A recent study conducted by HCMS Group, a human capital risk management firm that analyzes data to help employers reduce waste in health...